This page contains a Flash digital edition of a book.
Medical Imaging


CT radiation portion, which is typically 20-50 percent of the radiation burden of a PET scan. While this is not relevant in many patients suffering from malignant tumors, it may well be relevant in patients suffering from inflammatory disease and in the pediatric popu- lation. As stated above, a PET/CT-MR scan is a research mode designed to explore where PET/MR may be supe- rior to PET/CT imaging.


4. What, according to you, are the challenges we face with the onset of Pet/Ct +mr scan? The major challenge of a PET/CT-MR scan is that it is a lengthy procedure with high cost, as it really requires that all three modalities are used and potentially billed to the patient resulting in increasing healthcare costs. But as stat- ed above, this combination is designed mainly to evaluate whether and where the CT portion of the examination can be entirely replaced by MR.


5. Since molecular imaging is a rapidly evolving field, where do you expect to see it a few years from now?


Molecular imaging has made major inroads in tumor stag- ing and therapy monitoring and is bound to evolve further in this field.


The most prominent foreseeable clinical applica-


tion of PET will be in the earlier diagnosis of dementia. Whether, and in which form, PET/MR will be relevant in this application, has to be proven clinically. However, PET/CT seems not to be providing any major advantage over PET alone in this disease entity. MR is the anatom- ic method of choice in dementia and so a combination of PET and MR in these diseases may be beneficial. However, whether simultaneous PET/MR, sequential PET-MR or separate PET and MR supported by software image fusion will be the most appropriate way to clini- cally evaluate patients with dementia is currently not known. Systems such as PET/CT-MR are ideal systems to evaluate what kind of combination of imaging will be needed. Research applications of PET as a molecular imag-


ing tool in combination with CT or MR are innumerous and it is assumed that much of imaging research will focus on how to use these imaging tools in the next ten years. In the quest of understanding the role of PET, CT and MR in the research fields of oncology, inflam- mation, brain and cardiovascular disease it will also become clear, which kind of integrated imaging can be used to better advantage in these disease entities in a clinical setting.


www.hhmglobal.com


45


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56